285 lines
8.8 KiB
Markdown
285 lines
8.8 KiB
Markdown
|
|
# Standard Operating Procedure: Compounding Pediatric Oral Suspensions
|
|||
|
|
|
|||
|
|
| Document ID | SOP-COMP-001 |
|
|||
|
|
|-------------|---------|
|
|||
|
|
| Title | Compounding Pediatric Oral Suspensions from Solid Dosage Forms |
|
|||
|
|
| Revision | 1.0 |
|
|||
|
|
| Effective Date | [DATE] |
|
|||
|
|
| Author | [AUTHOR] |
|
|||
|
|
| Approved By | [APPROVER] |
|
|||
|
|
| Department | Pediatric Pharmacy - Compounding |
|
|||
|
|
|
|||
|
|
---
|
|||
|
|
|
|||
|
|
## 1. Purpose
|
|||
|
|
|
|||
|
|
To establish a standardized process for compounding oral suspensions from tablets or capsules to provide age-appropriate, accurately dosed medications for pediatric patients when commercial liquid formulations are unavailable.
|
|||
|
|
|
|||
|
|
## 2. Scope
|
|||
|
|
|
|||
|
|
This procedure applies to non-sterile compounding of oral suspensions from solid dosage forms for pediatric patients. It covers:
|
|||
|
|
- Crushing tablets or opening capsules
|
|||
|
|
- Preparing suspensions in appropriate vehicles
|
|||
|
|
- Flavoring for palatability
|
|||
|
|
- Labeling and beyond-use dating
|
|||
|
|
- Quality verification
|
|||
|
|
|
|||
|
|
This procedure does not apply to:
|
|||
|
|
- Hazardous drugs (see USP <800> procedures)
|
|||
|
|
- Sterile preparations
|
|||
|
|
- Commercial liquid formulations
|
|||
|
|
|
|||
|
|
## 3. Responsibilities
|
|||
|
|
|
|||
|
|
### 3.1 Pharmacist
|
|||
|
|
- Verifies formulation and calculations
|
|||
|
|
- Selects appropriate vehicle and flavoring
|
|||
|
|
- Determines beyond-use date
|
|||
|
|
- Performs final verification
|
|||
|
|
- Provides counseling on administration and storage
|
|||
|
|
|
|||
|
|
### 3.2 Pharmacy Technician
|
|||
|
|
- Prepares workspace
|
|||
|
|
- Compounds suspension following procedure
|
|||
|
|
- Labels container appropriately
|
|||
|
|
- Cleans and documents
|
|||
|
|
|
|||
|
|
### 3.3 Quality Reviewer
|
|||
|
|
- Verifies calculations independently
|
|||
|
|
- Checks final product
|
|||
|
|
- Approves for dispensing
|
|||
|
|
|
|||
|
|
## 4. Definitions
|
|||
|
|
|
|||
|
|
| Term | Definition |
|
|||
|
|
|------|------------|
|
|||
|
|
| Oral Suspension | Liquid dosage form containing solid particles dispersed in liquid vehicle |
|
|||
|
|
| Vehicle | Liquid base used to suspend active ingredient |
|
|||
|
|
| Beyond-Use Date (BUD) | Date after which compounded preparation should not be used |
|
|||
|
|
| Geometric Dilution | Technique for mixing small quantity with larger quantity by doubling proportions |
|
|||
|
|
| Ora-Plus/Ora-Sweet | Common suspending vehicle and sweetening agent for pediatric suspensions |
|
|||
|
|
|
|||
|
|
## 5. Equipment and Materials
|
|||
|
|
|
|||
|
|
### 5.1 Equipment
|
|||
|
|
- Mortar and pestle (appropriately sized)
|
|||
|
|
- Graduated cylinder (appropriate volume)
|
|||
|
|
- Amber or light-resistant bottle
|
|||
|
|
- Spatula
|
|||
|
|
- Weighing scale (class III or better)
|
|||
|
|
- Calibrated oral syringes for measuring
|
|||
|
|
|
|||
|
|
### 5.2 Materials
|
|||
|
|
- Solid dosage form (tablets or capsules)
|
|||
|
|
- Suspending vehicle (Ora-Plus, SyrSpend SF, methylcellulose, etc.)
|
|||
|
|
- Sweetening agent (Ora-Sweet, Ora-Sweet SF, syrup, etc.)
|
|||
|
|
- Flavoring (if needed)
|
|||
|
|
- Appropriate label
|
|||
|
|
- Compounding log
|
|||
|
|
|
|||
|
|
## 6. Procedure
|
|||
|
|
|
|||
|
|
### 6.1 Preparation and Planning
|
|||
|
|
|
|||
|
|
1. **Review Prescription**
|
|||
|
|
- Verify medication, strength, and quantity
|
|||
|
|
- Calculate total amount needed plus overage (typically 10-20%)
|
|||
|
|
- Determine final concentration
|
|||
|
|
- Check for drug-vehicle compatibility
|
|||
|
|
|
|||
|
|
2. **Select Vehicle and Flavoring**
|
|||
|
|
- Choose appropriate vehicle for medication stability
|
|||
|
|
- Consider patient age and preferences
|
|||
|
|
- Select sugar-free vehicles if appropriate (diabetic patients)
|
|||
|
|
- Choose flavoring (see Appendix A for flavor recommendations)
|
|||
|
|
|
|||
|
|
3. **Calculate Beyond-Use Date**
|
|||
|
|
- Reference stability data (published studies, manufacturers)
|
|||
|
|
- Apply USP <795> guidelines if no data available:
|
|||
|
|
- Aqueous formulations: Maximum 14 days refrigerated
|
|||
|
|
- Non-aqueous formulations: Maximum 30 days
|
|||
|
|
- Use most conservative date if multiple sources
|
|||
|
|
|
|||
|
|
4. **Gather Materials**
|
|||
|
|
- Obtain correct tablets/capsules (verify NDC)
|
|||
|
|
- Obtain vehicle and flavoring
|
|||
|
|
- Select appropriate bottle size
|
|||
|
|
- Prepare workspace
|
|||
|
|
|
|||
|
|
### 6.2 Compounding Process
|
|||
|
|
|
|||
|
|
1. **Hand Hygiene and Garbing**
|
|||
|
|
- Wash hands thoroughly
|
|||
|
|
- Don lab coat and gloves
|
|||
|
|
- No jewelry on hands/wrists
|
|||
|
|
|
|||
|
|
2. **Clean Workspace**
|
|||
|
|
- Disinfect compounding area
|
|||
|
|
- Ensure equipment is clean and dry
|
|||
|
|
- Remove unnecessary items
|
|||
|
|
|
|||
|
|
3. **Preparation of Solid Dosage Form**
|
|||
|
|
|
|||
|
|
**For Tablets:**
|
|||
|
|
- Count correct number of tablets
|
|||
|
|
- Place in mortar
|
|||
|
|
- Crush to fine, uniform powder
|
|||
|
|
- Triturate until no large particles remain
|
|||
|
|
|
|||
|
|
**For Capsules:**
|
|||
|
|
- Count correct number of capsules
|
|||
|
|
- Empty capsule contents into mortar
|
|||
|
|
- Discard empty capsule shells appropriately
|
|||
|
|
- Mix powder thoroughly
|
|||
|
|
|
|||
|
|
4. **Geometric Dilution with Vehicle**
|
|||
|
|
|
|||
|
|
- Measure small amount of vehicle (approximately equal volume to powder)
|
|||
|
|
- Add to powder in mortar
|
|||
|
|
- Triturate to form smooth paste (no lumps)
|
|||
|
|
- Add another equal portion of vehicle
|
|||
|
|
- Mix thoroughly
|
|||
|
|
- Continue doubling portions until all powder incorporated
|
|||
|
|
- Transfer to graduated cylinder
|
|||
|
|
|
|||
|
|
5. **Add Remaining Vehicle**
|
|||
|
|
|
|||
|
|
- Rinse mortar with vehicle to capture all medication
|
|||
|
|
- Transfer to graduated cylinder
|
|||
|
|
- Add vehicle to desired final volume
|
|||
|
|
- Add flavoring if using separate flavoring agent
|
|||
|
|
|
|||
|
|
6. **Mix Thoroughly**
|
|||
|
|
|
|||
|
|
- Cap bottle securely
|
|||
|
|
- Shake vigorously for 30 seconds
|
|||
|
|
- Visually inspect for uniform suspension
|
|||
|
|
- No clumps or settling immediately after shaking
|
|||
|
|
|
|||
|
|
### 6.3 Quality Checks
|
|||
|
|
|
|||
|
|
1. **Visual Inspection**
|
|||
|
|
- Color appropriate for ingredients
|
|||
|
|
- Smooth consistency (no large particles)
|
|||
|
|
- Uniform suspension when shaken
|
|||
|
|
- No visible contamination
|
|||
|
|
|
|||
|
|
2. **Volume Verification**
|
|||
|
|
- Final volume matches calculated volume (±5%)
|
|||
|
|
- Adequate overage to allow for bottle hold-up
|
|||
|
|
|
|||
|
|
3. **Concentration Verification**
|
|||
|
|
- Independent pharmacist verifies calculation
|
|||
|
|
- Example: 30 tablets × 100 mg = 3000 mg in 150 mL = 20 mg/mL
|
|||
|
|
|
|||
|
|
### 6.4 Labeling
|
|||
|
|
|
|||
|
|
Apply pharmacy label with following information:
|
|||
|
|
- Patient name and date of birth
|
|||
|
|
- Medication name and strength per volume (e.g., "20 mg/mL")
|
|||
|
|
- Directions for use
|
|||
|
|
- "SHAKE WELL BEFORE EACH USE"
|
|||
|
|
- Beyond-use date
|
|||
|
|
- Storage instructions (e.g., "Refrigerate" or "Store at room temperature")
|
|||
|
|
- "For Oral Use Only"
|
|||
|
|
- Flavor (if added)
|
|||
|
|
- Auxiliary labels as appropriate
|
|||
|
|
- Pharmacist initials
|
|||
|
|
- Compounding date
|
|||
|
|
|
|||
|
|
### 6.5 Final Verification
|
|||
|
|
|
|||
|
|
Pharmacist verifies:
|
|||
|
|
- Correct medication and strength
|
|||
|
|
- Accurate calculation
|
|||
|
|
- Appropriate concentration for patient age and weight
|
|||
|
|
- Correct labeling
|
|||
|
|
- BUD appropriate
|
|||
|
|
- Storage instructions clear
|
|||
|
|
- Oral syringe provided for accurate dosing
|
|||
|
|
|
|||
|
|
### 6.6 Counseling Points
|
|||
|
|
|
|||
|
|
Provide to patient/caregiver:
|
|||
|
|
- Shake well before each use
|
|||
|
|
- Use provided oral syringe for measuring (never household spoon)
|
|||
|
|
- Storage requirements (refrigerate if required)
|
|||
|
|
- Beyond-use date
|
|||
|
|
- What to do if dose missed
|
|||
|
|
- Possible side effects
|
|||
|
|
- Complete full course even if feeling better
|
|||
|
|
|
|||
|
|
### 6.7 Documentation
|
|||
|
|
|
|||
|
|
Complete compounding log with:
|
|||
|
|
- Date and time
|
|||
|
|
- Patient name
|
|||
|
|
- Medication and strength
|
|||
|
|
- Lot numbers of all ingredients
|
|||
|
|
- Expiration dates of ingredients
|
|||
|
|
- Calculations
|
|||
|
|
- Final concentration and volume
|
|||
|
|
- BUD assigned
|
|||
|
|
- Compounding pharmacist/technician
|
|||
|
|
- Verifying pharmacist
|
|||
|
|
|
|||
|
|
### 6.8 Cleanup
|
|||
|
|
|
|||
|
|
- Wash all equipment with hot soapy water
|
|||
|
|
- Rinse thoroughly and dry
|
|||
|
|
- Disinfect work surface
|
|||
|
|
- Dispose of waste appropriately
|
|||
|
|
- Return ingredients to storage
|
|||
|
|
|
|||
|
|
## 7. Common Pediatric Suspensions
|
|||
|
|
|
|||
|
|
| Medication | Typical Concentration | Vehicle | Stability (refrigerated) |
|
|||
|
|
|------------|----------------------|---------|--------------------------|
|
|||
|
|
| Atenolol | 2 mg/mL | Ora-Plus/Ora-Sweet (1:1) | 60 days |
|
|||
|
|
| Captopril | 1 mg/mL | Ora-Plus/Ora-Sweet (1:1) | 56 days |
|
|||
|
|
| Clonidine | 0.1 mg/mL | Ora-Plus/Ora-Sweet SF (1:1) | 91 days |
|
|||
|
|
| Enalapril | 1 mg/mL | Ora-Plus/Ora-Sweet SF (1:1) | 60 days |
|
|||
|
|
| Propranolol | 1 mg/mL | Ora-Plus/Ora-Sweet (1:1) | 42 days |
|
|||
|
|
| Spironolactone | 5 mg/mL | Ora-Plus/Ora-Sweet SF (1:1) | 60 days |
|
|||
|
|
|
|||
|
|
*Always verify stability data from current references before compounding*
|
|||
|
|
|
|||
|
|
## 8. Appendix A: Pediatric Flavoring Guide
|
|||
|
|
|
|||
|
|
| Age Group | Preferred Flavors |
|
|||
|
|
|-----------|-------------------|
|
|||
|
|
| Infants (< 1 year) | Minimize flavoring; consider mother's diet if breastfeeding |
|
|||
|
|
| Toddlers (1-3 years) | Cherry, grape, bubblegum, strawberry |
|
|||
|
|
| Children (4-12 years) | Watermelon, grape, cherry, bubblegum, chocolate |
|
|||
|
|
| Adolescents (13-18 years) | Fruit flavors, vanilla, chocolate |
|
|||
|
|
|
|||
|
|
| Medication Type | Flavoring Recommendation |
|
|||
|
|
|-----------------|--------------------------|
|
|||
|
|
| Bitter medications | Chocolate, vanilla, or cream flavors |
|
|||
|
|
| Salty medications | Citrus or fruit flavors |
|
|||
|
|
| Acidic medications | Fruit punch or grape |
|
|||
|
|
|
|||
|
|
## 9. Related Documents
|
|||
|
|
|
|||
|
|
- FRM-COMP-001 Compounding Record
|
|||
|
|
- Master Formulation Records (if established)
|
|||
|
|
- USP <795> Pharmaceutical Compounding - Nonsterile Preparations
|
|||
|
|
- Pediatric dosing references
|
|||
|
|
|
|||
|
|
## 10. References
|
|||
|
|
|
|||
|
|
- USP <795> Pharmaceutical Compounding - Nonsterile Preparations
|
|||
|
|
- ASHP Guidelines on Compounding Sterile Preparations
|
|||
|
|
- Trissel's Stability of Compounded Formulations
|
|||
|
|
- Paddock Laboratories Flavoring Guide
|
|||
|
|
- State Board of Pharmacy compounding regulations
|
|||
|
|
- Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients (ASHP)
|
|||
|
|
|
|||
|
|
---
|
|||
|
|
|
|||
|
|
## Revision History
|
|||
|
|
|
|||
|
|
| Rev | Date | Description | Author |
|
|||
|
|
|-----|------|-------------|--------|
|
|||
|
|
| 1.0 | [DATE] | Initial release | [AUTHOR] |
|